IP31-28 THE DIAGNOSTIC BENEFIT OF PERILESIONAL SAMPLING AT THE TIME OF CONFIRMATORY BIOPSY IN PATIENTS MANAGED WITH ACTIVE SURVEILLANCE FOR ISUP-GG 1 PROSTATE CANCER